Be confident in treatment and deferral decisions with Philips iFR.1,2
No other resting index has an ACC/AHA/SCAI Class IA recommendation based on the high level of clinical evidence for its accuracy. Philips iFR is the Gold Standard.1,2 iFR is the leading hyperemia-free physiologic index for measuring pressure in diagnostic and interventional procedures. Only offered by Philips, iFR is an evidence-based methodology that improves outcomes, saves time, and reduces patient discomfort.1,2,3 iFR Co-registration maps the physiologic measurements directly onto the angiogram enabling more complete procedural guidance.
Only Philips iFR has a Class IA recommendation by the ACC/AHA/SCAI and ESC1,3
Only iFR has clinically validated patient outcome data in the largest physiology studies ever
Only iFR has co-registration for advanced physiologic guidance
With an all new workhorse design, only OmniWire combines confidence in wire performance with proven iFR outcomes and iFR Co-registration, making it easy to benefit from physiology throughout the case.
Unseen focal lesions cause residual ischemia4
Map iFR values directly onto the angiogram, so you can see precisely which parts of a vessel are causing ischemia
Available on the new Philips IntraSight interventional applications platform and as an upgrade to the Core systems.
Dr. Justin Davies explains how iFR Co-registration can identify disease location and the likely impact of PCI before you stent.
Dr. Allen Jeremias explains the need to understand not just whether there is ischemia, but where it is when planning for PCI
Introducing the all-new Philips IntraSight interventional applications platform where imaging, physiology, co-registration3 and software come together to facilitate optimal patient care. IntraSight offers a comprehensive suite of clinically proven modalities, such as, iFR/FFR, IVUS and co-registration to simplify complex interventions, speed routine procedures and provide improved patient care.
1. Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129. 2. Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59. 3. 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96. 4. Jeremias A et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019 Oct 28;12(20):1991-2001. 5. Co-registration tools available within IntraSight 7 configuration via SyncVision.
You are about to visit a Philips global content page
Continue